Last $0.04 USD
Change Today 0.00 / 0.00%
Volume 0.0
GNTLF On Other Exchanges
Symbol
Exchange
OTC US
NASDAQ CM
Frankfurt
As of 8:10 PM 08/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Alison J. Mew MSc Hons

Chief Executive Officer, Genetic Technologies Limited
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

56A$255,333
As of Fiscal Year 2013

Background*

Ms. Alison J. Mew, MSc Hons, has been Chief Executive Officer of Genetic Technologies Limited since December 10, 2012. Ms. Mew served as the Chief Operating Officer of Genetic Technologies Limited since August 31, 2009 and also served as its Acting Chief Executive Officer until November 28, 2012. Ms. Mew had extensive experience in the bio-pharmaceutical industry in operations management roles - both in Australia and overseas. Her most recent corporate experience was ...

Read Full Background

Corporate Headquarters*

60-66 Hanover Street
Fitzroy, Victoria 3065

Australia

Phone: 61 3 8412 7000
Fax: 61 3 8412 7040

Board Members Memberships*

2012-N/A
Director and Member of Audit Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

SalaryA$223,133
Total Annual CompensationA$223,133

Stock Options*

All Other CompensationA$32,200
Exercised Options1,500,000
Total Number of Options1,500,000

Total Compensation*

Total Annual Cash CompensationA$255,333
Total Short Term CompensationA$223,133
Other Long Term CompensationA$32,200
Total Calculated CompensationA$255,333
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNTLF:US $0.04 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
William P. Sullivan Chief Executive Officer, Executive Director and Member of Executive Committee
Agilent Technologies Inc.
$1.0M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Colin Stephen Goldschmidt M.B., B.Ch., F.R.C.P.A., F.A.I.C.D.Chief Executive Officer, Managing Director, Executive Director, Member of Risk Management Committee and Chief Executive Officer of Douglass Hanly Moir Pathology
Sonic Healthcare Limited
A$2.3M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENETIC TECHNOLOGIES LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.